Amyloidosis Support Groups Inc (EIN 202909816) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

Muriel Finkel

Phone

8664047539

Tax Period

2023-06-01 to 2024-05-31

Amyloidosis Support Groups Inc, founded in 2005, is a small nonprofit in the Medical Research sector that reported $430K in total revenue in fiscal year 2023. Revenue surged 58% from the prior year, signaling strong growth momentum. Net assets of $878K represent 25 months of operating reserves.

Mission

To form Amyloidosis Support Groups were needed, to have all Amyloidosis support Groups be self sustaining through donations, to fund and maintain libraries of education materials for all support groups, to fund group projects that wil help in spreading awareness and fundraising and to help finance the annual education retreat for training new and current group leaders and facilitators.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $410,658

Program Service Revenue $0

Investment Income $18,888

Other Revenue $0

TOTAL REVENUE $429,546

Expense Breakdown

Grants Paid $2,500

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $437,356

Other Expenses $451,253

TOTAL EXPENSES $453,753

Year-over-Year Comparison

	2023	2022	Change
Revenue	$429,546	$271,494	+0.6%
Expenses	$453,753	$130,946	+2.5%
Net Income	$-24,207	$140,548	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Muriel Finkel	President	50.00	Officer Director	$0	$0	$0
Jennifer Celano	Vice President	5.00	Officer Director	$0	$0	$0
Stephen Finkel	Treasurer	20.00	Officer Director	$0	$0	$0
Joseph Gibson	Secretary	5.00	Officer Director	$0	$0	$0
Paula Schmitt	Director	10.00	Director	$0	$0	$0
Patricia Gibson	Public Policy	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$429,546	$453,753	$884,795	$-24,207
2023	$271,494	$130,946	$904,312	$140,548
2022	$129,929	$109,828	$762,531	$20,101
2021	$107,843	$64,861	$742,537	$42,982
2020	$545,856	$403,466	$702,307	$142,390
2019	$410,777	$191,900	$564,959	$218,877

Amyloidosis Support Groups Inc